211 related articles for article (PubMed ID: 38359559)
21. Directed evolution of a soluble human DR3 receptor for the inhibition of TL1A induced cytokine secretion.
Levin I; Zaretsky M; Aharoni A
PLoS One; 2017; 12(3):e0173460. PubMed ID: 28278297
[TBL] [Abstract][Full Text] [Related]
22. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.
Twohig JP; Marsden M; Cuff SM; Ferdinand JR; Gallimore AM; Perks WV; Al-Shamkhani A; Humphreys IR; Wang EC
FASEB J; 2012 Aug; 26(8):3575-86. PubMed ID: 22593543
[TBL] [Abstract][Full Text] [Related]
23. The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells.
Meylan F; Hawley ET; Barron L; Barlow JL; Penumetcha P; Pelletier M; Sciumè G; Richard AC; Hayes ET; Gomez-Rodriguez J; Chen X; Paul WE; Wynn TA; McKenzie AN; Siegel RM
Mucosal Immunol; 2014 Jul; 7(4):958-68. PubMed ID: 24368564
[TBL] [Abstract][Full Text] [Related]
24. TL1A-DR3 Plasma Levels Are Predictive of HIV-1 Disease Control, and DR3 Costimulation Boosts HIV-1-Specific T Cell Responses.
Oriol-Tordera B; Olvera A; Duran-Castells C; Llano A; Mothe B; Massanella M; Dalmau J; Ganoza C; Sanchez J; Calle ML; Clotet B; Martinez-Picado J; Negredo E; Blanco J; Hartigan-O'Connor D; Brander C; Ruiz-Riol M
J Immunol; 2020 Dec; 205(12):3348-3357. PubMed ID: 33177161
[TBL] [Abstract][Full Text] [Related]
25. Death receptor 3 is essential for generating optimal protective CD4⁺ T-cell immunity against Salmonella.
Buchan SL; Taraban VY; Slebioda TJ; James S; Cunningham AF; Al-Shamkhani A
Eur J Immunol; 2012 Mar; 42(3):580-8. PubMed ID: 22259035
[TBL] [Abstract][Full Text] [Related]
26. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
[TBL] [Abstract][Full Text] [Related]
27. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
29. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells.
Wen L; Zhuang L; Luo X; Wei P
J Biol Chem; 2003 Oct; 278(40):39251-8. PubMed ID: 12882979
[TBL] [Abstract][Full Text] [Related]
30. Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.
Madireddi S; Eun SY; Mehta AK; Birta A; Zajonc DM; Niki T; Hirashima M; Podack ER; Schreiber TH; Croft M
J Immunol; 2017 Oct; 199(8):2721-2728. PubMed ID: 28877989
[TBL] [Abstract][Full Text] [Related]
31. Death Receptor 3 Promotes Chemokine-Directed Leukocyte Recruitment in Acute Resolving Inflammation and Is Essential for Pathological Development of Mesothelial Fibrosis in Chronic Disease.
Perks WV; Singh RK; Jones GW; Twohig JP; Williams AS; Humphreys IR; Taylor PR; Jones SA; Wang ECY
Am J Pathol; 2016 Nov; 186(11):2813-2823. PubMed ID: 27664471
[TBL] [Abstract][Full Text] [Related]
32. Oestrogen-deficiency induces bone loss by modulating CD14
Collins FL; Stone MD; Turton J; McCabe LR; Wang ECY; Williams AS
BMC Musculoskelet Disord; 2019 Jul; 20(1):326. PubMed ID: 31299941
[TBL] [Abstract][Full Text] [Related]
33. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.
Migone TS; Zhang J; Luo X; Zhuang L; Chen C; Hu B; Hong JS; Perry JW; Chen SF; Zhou JX; Cho YH; Ullrich S; Kanakaraj P; Carrell J; Boyd E; Olsen HS; Hu G; Pukac L; Liu D; Ni J; Kim S; Gentz R; Feng P; Moore PA; Ruben SM; Wei P
Immunity; 2002 Mar; 16(3):479-92. PubMed ID: 11911831
[TBL] [Abstract][Full Text] [Related]
34. Immunobiology of TNFSF15 and TNFRSF25.
Schreiber TH; Podack ER
Immunol Res; 2013 Dec; 57(1-3):3-11. PubMed ID: 24242819
[TBL] [Abstract][Full Text] [Related]
35. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
Aiba Y; Nakamura M
Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
[TBL] [Abstract][Full Text] [Related]
36. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
[TBL] [Abstract][Full Text] [Related]
37. Multifaceted death receptor 3 signaling-promoting survival and triggering death.
Bittner S; Ehrenschwender M
FEBS Lett; 2017 Sep; 591(17):2543-2555. PubMed ID: 28686297
[TBL] [Abstract][Full Text] [Related]
38. Death receptor 3 signaling enhances proliferation of human regulatory T cells.
Bittner S; Knoll G; Ehrenschwender M
FEBS Lett; 2017 Apr; 591(8):1187-1195. PubMed ID: 28337757
[TBL] [Abstract][Full Text] [Related]
39. The adaptor protein TRADD is essential for TNF-like ligand 1A/death receptor 3 signaling.
Pobezinskaya YL; Choksi S; Morgan MJ; Cao X; Liu ZG
J Immunol; 2011 May; 186(9):5212-6. PubMed ID: 21421854
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-like cytokine 1A plays a role in inflammatory bowel disease pathogenesis.
Meng F; Jiang X; Wang X; Zheng Q; Wang XN; Mei C; Yan S; He Y; Xue J; Zhang X; Fu W; You Y; Zhai J; Wang Y; Sun X
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2120771120. PubMed ID: 37579137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
